NCT04651959View on ClinicalTrials.gov

Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 13, 2020

Primary Completion Date

November 18, 2020

Study Completion Date

December 20, 2020

Conditions
Bioequivalence
Interventions
DRUG

AVICOD 200 MG Film Tablet

AVICOD is containing 200 mg favipiravir manufactured by Pharma Plant,Turkey.

DRUG

AVIGAN 200 MG Film Tablets

AVIGAN is containing 200 mg favipiravir manufactured by Toyama, Japan

Trial Locations (1)

06970

Novagenix Drug R&D Center, Akyurt

Sponsors

Lead Sponsor

Pharma Plant
All Listed Sponsors
collaborator

Novagenix Bioanalytical Drug R&D Center

NETWORK

lead

Pharma Plant

INDUSTRY

NCT04651959 - Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions | Biotech Hunter | Biotech Hunter